Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crowʼs Feet
- 1 March 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Dermatologic Surgery
- Vol. 31 (3), 257-262
- https://doi.org/10.1097/00042728-200503000-00001